Neuronal nicotinic acetylcholine receptor alpha-6-containing subtype (alpha-6* nAChR)

Neuronal nicotinic acetylcholine receptors (nAChRs) containing the alpha-6 subunit are pentameric ligand-gated ion channels primarily expressed in the midbrain dopaminergic system, including the substantia nigra and ventral tegmental area, as well as the retina and locus coeruleus (PubMed: 18055561, UniProt: Q9R0W9). These receptors typically assemble as heteromers, such as alpha-6-beta-2* or alpha-4-alpha-6-beta-2*, and are critical regulators of neurotransmitter release, particularly dopamine in the striatum and nucleus accumbens (PubMed: 18719211, Wikipedia). By modulating dopaminergic signaling, alpha-6-containing nAChRs play a central role in reward processing, motivation, and the regulation of locomotor activity (PubMed: 21325521, NIH). They are heavily implicated in the pathophysiology of nicotine and alcohol dependence, as they mediate the reinforcing effects of these substances through the mesolimbic pathway (PubMed: 18055561, MDPI). In Parkinson's disease, these receptors are among the most vulnerable to neurodegeneration, and their loss correlates with motor deficits, making them a key target for neuroprotective and symptomatic treatments (PubMed: 18719211, Guide to Pharmacology). Pharmacologically, they exhibit high sensitivity to nicotine and are uniquely sensitive to specific antagonists like alpha-conotoxin MII and PIA, which are used to distinguish them from other nAChR subtypes (PubMed: 12944511, Guide to Pharmacology). Therapeutic strategies targeting these receptors include the development of selective agonists and partial agonists to treat addiction and neurodegenerative disorders while minimizing off-target effects on peripheral nicotinic receptors (PubMed: 38921452, NIH).

Other names

CHRNA6-containing nAChRalpha6-containing nicotinic receptoralpha6* nAChRnAChR alpha 6 subunit-containing receptorCholinergic receptor nicotinic alpha 6 subunit-containing receptor

Ligand-gated ion channel activation leading to cation influx (Na+, Ca2+), membrane depolarization, and subsequent modulation of neurotransmitter release, particularly dopamine in the striatum and nucleus accumbens (PubMed: 12944511, Wikipedia).